MetLife Investment Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $264K | Hold |
|
|||||
|
2025
Q2 | $245K | Hold |
|
|||||
|
2025
Q1 | $250K | Buy |
|
|||||
|
2024
Q4 | $162K | Sell |
|
|||||
|
2024
Q3 | $258K | Hold |
|
|||||
|
2024
Q2 | $263K | Buy |
|
|||||
|
2024
Q1 | $199K | Hold |
|
|||||
|
2023
Q4 | $206K | Buy |
|
|||||
|
2023
Q3 | $120K | Hold |
|
|||||
|
2023
Q2 | $112K | Hold |
|
|||||
|
2023
Q1 | $98.2K | Hold |
|
|||||
|
2022
Q4 | $84.5K | Hold |
|
|||||
|
2022
Q3 | $181K | Hold |
|
|||||
|
2022
Q2 | $123K | Hold |
|
|||||
|
2022
Q1 | $184K | Buy |
|
|||||
|
2021
Q4 | $81.1K | Hold |
|
|||||
|
2021
Q3 | $107K | Hold |
|
|||||
|
2021
Q2 | $147K | Hold |
|
|||||
|
2021
Q1 | $157K | Sell |
|
|||||
|
2020
Q4 | $135K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $139K | Buy |
|